Lodestone Biomedical

Lodestone Biomedical Overview

Founded 2015
Status Private
Employees 3
Latest Deal Type Angel
Latest Deal Amount $660K
Latest Deal Amount
Investors 1

Lodestone Biomedical General Information


Operator of a response prediction platform intended to serve oncologists and patients. The company' magnetic systems and implanted nanosensors provide continuous monitoring of tumor-immune activity to inform the most effective cancer treatment decisions, enabling healthcare providers and patients to know whether or not a therapy is working within days of a first dose.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 10 Water Street
  • Suite 265
  • Lebanon, NH 03766
  • United States
+1 (603) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Lodestone Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Angel (individual) 06-Apr-2020 $660K 00000 Completed Generating Revenue
1. Accelerator/Incubator 20-May-2015 Completed Startup

Lodestone Biomedical Executive Team (3)

Name Title Board Seat Contact Info
Solomon Diamond Ph.D Chief Executive Officer & Board Member
Christian Knopke Ph.D Chief Operating Officer

1 Former Executive

Lodestone Biomedical Board Members (1)

Name Representing Role Since
Solomon Diamond Ph.D Lodestone Biomedical Chief Executive Officer & Board Member 000 0000

Lodestone Biomedical Investors (1)

To view Lodestone Biomedical‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
MassChallenge Accelerator/Incubator 000 0000 000000 0

Ready to get started?

Request a free trial